These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 28070092

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Re-response to tolvaptan after furosemide dose reduction in a patient with refractory ascites.
    Goto A, Terai S, Nakamura M, Matsumoto M, Sakaida I.
    Clin J Gastroenterol; 2015 Feb; 8(1):47-51. PubMed ID: 25475138
    [Abstract] [Full Text] [Related]

  • 3. Tolvaptan for the treatment of liver cirrhosis oedema.
    Sakaida I.
    Expert Rev Gastroenterol Hepatol; 2014 Jul; 8(5):461-70. PubMed ID: 24678622
    [Abstract] [Full Text] [Related]

  • 4. Cell-free and Concentrated Ascites Reinfusion Therapy for Refractory Ascites in Cirrhosis in Post-marketing Surveillance and the Role of Tolvaptan.
    Iwasa M, Ishihara T, Kato M, Isoai A, Kobayashi R, Torii N, Soneda N, Takei Y.
    Intern Med; 2019 Nov 01; 58(21):3069-3075. PubMed ID: 31292400
    [Abstract] [Full Text] [Related]

  • 5. Cases with Refractory Ascites and a Delayed Response to Tolvaptan.
    Hagiwara S, Nishida N, Chishina H, Ida H, Sakurai T, Komeda Y, Kitano M, Kudo M.
    Intern Med; 2016 Nov 01; 55(22):3273-3277. PubMed ID: 27853068
    [Abstract] [Full Text] [Related]

  • 6. Clinical Factors Predicting the Effect of Tolvaptan for Refractory Ascites in Patients with Decompensated Liver Cirrhosis.
    Chishina H, Hagiwara S, Nishida N, Ueshima K, Sakurai T, Ida H, Minami Y, Takita M, Kono M, Minami T, Iwanishi M, Umehara Y, Watanabe T, Komeda Y, Arizumi T, Kudo M.
    Dig Dis; 2016 Nov 01; 34(6):659-664. PubMed ID: 27750234
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Clinical efficacy of tolvaptan for treatment of refractory ascites in liver cirrhosis patients.
    Zhang X, Wang SZ, Zheng JF, Zhao WM, Li P, Fan CL, Li B, Dong PL, Li L, Ding HG.
    World J Gastroenterol; 2014 Aug 28; 20(32):11400-5. PubMed ID: 25170228
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Efficacy of tolvaptan for the patients with advanced hepatocellular carcinoma.
    Miyazaki M, Yada M, Tanaka K, Senjyu T, Goya T, Motomura K, Kohjima M, Kato M, Masumoto A, Kotoh K.
    World J Gastroenterol; 2017 Aug 07; 23(29):5379-5385. PubMed ID: 28839438
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Tolvaptan treatment improves survival of cirrhotic patients with ascites and hyponatremia.
    Wang S, Zhang X, Han T, Xie W, Li Y, Ma H, Liebe R, Weng H, Ding HG.
    BMC Gastroenterol; 2018 Sep 04; 18(1):137. PubMed ID: 30180806
    [Abstract] [Full Text] [Related]

  • 15. The V2 receptor antagonist tolvaptan raises cytosolic calcium and prevents AQP2 trafficking and function: an in vitro and in vivo assessment.
    Tamma G, Di Mise A, Ranieri M, Geller A, Tamma R, Zallone A, Valenti G.
    J Cell Mol Med; 2017 Sep 04; 21(9):1767-1780. PubMed ID: 28326667
    [Abstract] [Full Text] [Related]

  • 16. Hyponatremia in cirrhosis: pathophysiology and management.
    John S, Thuluvath PJ.
    World J Gastroenterol; 2015 Mar 21; 21(11):3197-205. PubMed ID: 25805925
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Predictive factors of the pharmacological action of tolvaptan in patients with liver cirrhosis: a post hoc analysis.
    Sakaida I, Terai S, Nakajima K, Shibasaki Y, Tachikawa S, Tsubouchi H.
    J Gastroenterol; 2017 Feb 21; 52(2):229-236. PubMed ID: 27379386
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.